Armstrong Pharmaceuticals Inc
Pharmaceutical ManufacturingMassachusetts, United States11-50 Employees
Armstrong Pharmaceuticals Inc is a pharmaceuticals company based out of 25 John Rd, Canton, MA, United States.
Niche Market Potential With a focused team of 11-50 employees and revenue between $25M and $50M, Armstrong Pharmaceuticals Inc likely operates in a specialized segment of the pharmaceutical manufacturing industry, representing opportunities for tailored partnership or supply chain collaborations.
Emerging Regional Player Based in Canton, Massachusetts, the company's geographical location positions it well to serve the northeastern US market, and potential expansion could open doors to exploring nearby healthcare providers and biotech firms.
Growth Opportunities Revenues nearing the lower end of the $25M-$50M range suggest room for growth, indicating potential for strategic initiatives, such as innovative product development or market expansion, that sales teams can target.
Technology Adoption Although specific tech stack details are not provided, the company's presence in pharmaceutical manufacturing signals potential interest in advanced manufacturing technologies and digital solutions for operational efficiency.
Competitive Landscape Positioned alongside industry giants like Roche and Bristol-Myers Squibb, Armstrong Pharmaceuticals can leverage niche specialization or personalized services to build competitive advantages and attract business from similar-sized clients or niche markets.
| Armstrong Pharmaceuticals Inc Email Formats | Percentage |
| FirstL@armstrong-pharma.com | 72% |
| First.Last@armstrong-pharma.com | 12% |
| FLast@armstrong-pharma.com | 8% |
| LFirst@armstrong-pharma.com | 8% |
Pharmaceutical ManufacturingMassachusetts, United States11-50 Employees
Armstrong Pharmaceuticals Inc is a pharmaceuticals company based out of 25 John Rd, Canton, MA, United States.
Armstrong Pharmaceuticals Inc's revenue is estimated to be in the range of $25M$50M
Armstrong Pharmaceuticals Inc's revenue is estimated to be in the range of $25M$50M